Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Bailly

Showing results (81-90 of 290) with videos related to

Pageof 29
Sort By:
Pesticide Biochemistry and Physiology|July 27, 2020
Fraxinellone: From pesticidal control to cancer treatmentChristian Bailly, Gérard Vergoten
Pharmacology & Therapeutics|June 28, 2020
Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?Christian Bailly, Gérard Vergoten
Computational Biology and Chemistry|July 6, 2020
N-glycosylation of High Mobility Group Box 1 protein (HMGB1) modulates the interaction with glycyrrhizin: A molecular modeling studyGérard Vergoten, Christian Bailly
Cancers|April 13, 2023
Targeting of Tetraspanin CD81 with Monoclonal Antibodies and Small Molecules to Combat Cancers and Viral DiseasesChristian Bailly, Xavier Thuru
Bulletin Du Cancer|June 13, 2003
[A symphony for the camptothecins]Amélie Lansiaux, Christian Bailly
Journal of Receptor and Signal Transduction Research|November 18, 2021
Molecular docking study of britannin binding to PD-L1 and related anticancer pseudoguaianolide sesquiterpene lactonesGérard Vergoten, Christian Bailly
In Silico Pharmacology|May 3, 2021
In silico analysis of the antidiabetic terpenoid acankoreagenin binding to PPARγGérard Vergoten, Christian Bailly
Bulletin Du Cancer|March 1, 2003
[Perspectives on the oncologist pharmacopoeia]Amélie Lansiaux, Christian Bailly
Drug Discovery Today|February 13, 2021
A new horizon for the old antibacterial drug clofoctolChristian Bailly, Gérard Vergoten
Current Research in Pharmacology and Drug Discovery|December 15, 2021
Interaction of obtusilactone B and related butanolide lactones with the barrier-to-autointegration factor 1 (BAF1). A computational studyChristian Bailly, Gérard Vergoten
Pageof 29

Showing results (81-90 of 290) with videos related to

Sort By:
Pageof 29
Pesticide Biochemistry and Physiology|July 27, 2020
Fraxinellone: From pesticidal control to cancer treatmentChristian Bailly, Gérard Vergoten
Pharmacology & Therapeutics|June 28, 2020
Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?Christian Bailly, Gérard Vergoten
Computational Biology and Chemistry|July 6, 2020
N-glycosylation of High Mobility Group Box 1 protein (HMGB1) modulates the interaction with glycyrrhizin: A molecular modeling studyGérard Vergoten, Christian Bailly
Cancers|April 13, 2023
Targeting of Tetraspanin CD81 with Monoclonal Antibodies and Small Molecules to Combat Cancers and Viral DiseasesChristian Bailly, Xavier Thuru
Bulletin Du Cancer|June 13, 2003
[A symphony for the camptothecins]Amélie Lansiaux, Christian Bailly
Journal of Receptor and Signal Transduction Research|November 18, 2021
Molecular docking study of britannin binding to PD-L1 and related anticancer pseudoguaianolide sesquiterpene lactonesGérard Vergoten, Christian Bailly
In Silico Pharmacology|May 3, 2021
In silico analysis of the antidiabetic terpenoid acankoreagenin binding to PPARγGérard Vergoten, Christian Bailly
Bulletin Du Cancer|March 1, 2003
[Perspectives on the oncologist pharmacopoeia]Amélie Lansiaux, Christian Bailly
Drug Discovery Today|February 13, 2021
A new horizon for the old antibacterial drug clofoctolChristian Bailly, Gérard Vergoten
Current Research in Pharmacology and Drug Discovery|December 15, 2021
Interaction of obtusilactone B and related butanolide lactones with the barrier-to-autointegration factor 1 (BAF1). A computational studyChristian Bailly, Gérard Vergoten
Pageof 29